KLOW 45mg

OVERVIEW

KLOW (45mg) is one of the reference peptides New Zealand Peptides keeps in stock for laboratory research, alongside our flagship line-up headed by Retatrutide. It is referenced in research protocols for its reproducibility, lyophilised shelf stability, and straightforward reconstitution. Each KLOW vial is produced in accredited peptide blending and synthesis facilities and independently batch-tested for identity, purity and consistency before it is released for sale. Supplied as a 45mg lyophilised powder, KLOW sits alongside the rest of our proprietary research blends range for controlled, in-vitro experimental work.

KEY FEATURES

• High-purity KLOW research peptide
• 45mg lyophilised powder per vial
• HPLC-MS verified purity (99.00%)
• Produced in accredited laboratories
• Sterile, tamper-evident vial
• Dispatched from New Zealand before the 2pm cut-off

SPECIFICATIONS

Product Name

KLOW 45mg

Peptide Grade

Research Grade

Quantity

45mg per vial

Form

Lyophilised powder

Purity

99.00% (HPLC-MS tested)

Appearance

White / off-white lyophilised powder

Storage

Cool, dry; refrigerate for long-term stability

Packaging

Sterile, tamper-evident vial

WHY ORDER FROM NEW ZEALAND PEPTIDES

New Zealand Peptides sources and tests every batch we sell, from Retatrutide and Tirzepatide through to the rest of the bench. KLOW is HPLC-MS verified for identity and purity before release, then dispatched NZ-wide by NZ Post Courier in discreet packaging, with free tracked shipping on orders over $100 NZD. Bulk pricing applies across multi-vial orders and our support team can be reached at support@newzealandpeptides.co.nz.